Gland Pharma’s Visakhapatnam facilities clear USFDA inspection with zero observations
The inspection was conducted from August 24 to September 1, 2026
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
API manufacturing
Power, politics and pharma
In a world shaped by geopolitics, economic nationalism and heightened scrutiny on quality and resilience, India's next phase of…
Morepen Laboratories secures ₹825 Cr CDMO mandate from global pharma company
Multi-year contract to commence supplies within 4–5 months, execution planned through Q1 of next financial year
Indoco Remedies receives USFDA EIR for Patalganga API facility
USFDA inspection confirms compliance at Indoco Remedies’ Active Pharmaceutical Ingredients manufacturing site
Lupin achieves GMP Certification from TGA Australia for dabhasa API facility
LMS offers pharma CDMO services and manufactures APIs
Budget expectations: Leaders opine for incentives in the nutra and API manufacturing sectors
Industry players urge the government to prioritise funding for research into botanical herbs and address the challenge of API…
Dr Reddy’s receives EIR for API manufacturing facility
Inspection concluded at its API manufacturing facility in Srikakulam, Andhra Pradesh
Cadila Pharma launches API manufacturing plant at Dahej
Equipped with Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs 200…
USFDA completes GMP inspection of Dr Reddy’s Hyderabad API manufacturing facility
The inspection closed with zero observations
Road ahead for self-sustained API manufacturing
Dr Sanjay Chaturvedi, ED and CEO, IOL Chemicals and Pharmaceuticals stresses that as the Indian pharmaceutical industry continues…